Formula powder used for phenylketonuria patient, and preparation method for formula powder
A kind of technology of phenylketonuria and formula powder, applied in the field of formula powder and preparation thereof
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0031] The formula powder for patients with phenylketonuria of the present invention is prepared from the following components by mass percentage: vegetable oil fat powder 82.26%, compound amino acid 14%, nucleotide 0.03%, docosahexaenoic acid (DHA ) 0.05%, arachidonic acid (ARA) 0.09%, essence 0.1%, multivitamins 0.57% and multiminerals 2.9%, the formula powder does not contain phenylalanine.
[0032] The compound amino acid is composed of the following components by mass percentage: L-alanine 0.2-0.4%, L-arginine 0.2-0.5%, L-aspartic acid 0.7-1.0%, L-cystine 0.15% -0.35%, L-Glutamine 1.6-2.0%, Glycine 0.1-0.3%, L-Histidine 0.3-0.5%, L-Isoleucine 0.8-1.1%, L-Leucine 1.4-1.6% , L-lysine hydrochloride 0.8-1.2%, L-methionine 0.2-0.4%, L-proline 0.8-1.1%, L-serine 0.3-0.6%, L-threonine 0.5-0.7% , L-tryptophan 0.2-0.4%, L-tyrosine 0.8-1.2% and L-valine 0.8-1.2%.
[0033] The vegetable oil fat powder is prepared by spray drying solid glucose syrup, pregelatinized starch, fatty ac...
Embodiment 2
[0047] The formula powder for patients with phenylketonuria of the present invention is prepared from the following components in mass percentage:
[0048] Vegetable oil fat powder 79.883%, compound amino acid 14%, fructo-oligosaccharide (Fos) 0.1%, galacto-oligosaccharide (Gos) 0.9%, nucleotide 0.05%, docosahexaenoic acid (DHA) 0.0525%, di 0.0945% arachidonic acid (ARA), 0.3% essence, 0.12% multivitamin and 4.5% multivitamin, and the formula powder does not contain phenylalanine.
[0049] The compound amino acid is composed of the following components by mass percentage: L-alanine 0.2-0.4%, L-arginine 0.2-0.5%, L-aspartic acid 0.7-1.0%, L-cystine 0.15% -0.35%, L-Glutamine 1.6-2.0%, Glycine 0.1-0.3%, L-Histidine 0.3-0.5%, L-Isoleucine 0.8-1.1%, L-Leucine 1.4-1.6% , L-lysine hydrochloride 0.8-1.2%, L-methionine 0.2-0.4%, L-proline 0.8-1.1%, L-serine 0.3-0.6%, L-threonine 0.5-0.7% , L-tryptophan 0.2-0.4%, L-tyrosine 0.8-1.2% and L-valine 0.8-1.2%.
[0050] The vegetable oil f...
Embodiment 3
[0064] The formula powder for patients with phenylketonuria of the present invention is prepared from the following components in mass percentage:
[0065] Vegetable oil fat powder 88.296%, compound amino acid 8%, nucleotide 0.035%, docosahexaenoic acid (DHA) 0.045%, arachidonic acid (ARA) 0.081%, essence 0.5%, multivitamin 0.087% and Multimineral 2.956%, the formula does not contain phenylalanine.
[0066] The compound amino acid is composed of the following components by mass percentage: L-alanine 0.2-0.4%, L-arginine 0.2-0.5%, L-aspartic acid 0.7-1.0%, L-cystine 0.15% -0.35%, L-Glutamine 1.6-2.0%, Glycine 0.1-0.3%, L-Histidine 0.3-0.5%, L-Isoleucine 0.8-1.1%, L-Leucine 1.4-1.6% , L-lysine hydrochloride 0.8-1.2%, L-methionine 0.2-0.4%, L-proline 0.8-1.1%, L-serine 0.3-0.6%, L-threonine 0.5-0.7% , L-tryptophan 0.2-0.4%, L-tyrosine 0.8-1.2% and L-valine 0.8-1.2%.
[0067] The vegetable oil fat powder is prepared by spray drying solid glucose syrup, pregelatinized starch, fa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com